Open Nav

Merck & Co., Inc.

  • Alex Szidon, Merck

Provide key company information as well as a business development & licensing update.

  • Date:Wednesday, October 17
  • Time:2:00 PM - 2:15 PM
  • Room:Elizabethan D
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Publicly Traded Company
  • Company Description/Mission Statement:A Legacy of Innovation Merck has a strong history of success in translating cutting-edge research into life-saving medical breakthroughs. Our scientific advances have made a difference in the lives of millions of patients worldwide. From Merck’s development of the first measles and mumps vaccines to treatments for cancer and diabetes, we are an industry leader in bringing forth innovative new medicines. Partnering With Merck In 2017, over 60% of our human health sales were attributable to alliance partnerships and patents. With more than 100 significant business development transactions since 2016, our team has experience working on collaborations from discovery to clinical-stage programs. We believe that by working together we can play a major role in transforming global health care. Together we can invent for life. Learn more at merck.com/licensing.
  • Company Website:www.merck.com
  • Company HQ City:Kenilworth
  • Company HQ Country:United States
  • Company HQ State:New Jersey                 
  • Ticker:MRK
  • Exchange:NYSE
  • CEO/Top Company Official:Kenneth Frazier
  • Year Founded:1891
  • Main Therapeutic Focus:Multiple Therapeutics
  • Lead Product in Development :Multiple
  • Development Phase of Primary Product:Multiple Products in Market
Speakers
Alex Szidon
Merck
Back